Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
February 22 2016 - 1:44PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File No. 001-36855
Ocata
Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
33 Locke Drive
Marlborough, Massachusetts 01752
(508) 756-1212
(Address,
including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, par
value $0.001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)
Please place an
X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1) |
|
x |
Rule 12g-4(a)(2) |
|
¨ |
Rule 12h-3(b)(1)(i) |
|
x |
Rule 12h-3(b)(1)(ii) |
|
¨ |
Rule 15d-6 |
|
¨ |
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Ocata Therapeutics, Inc. has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
Ocata Therapeutics, Inc. |
Date: February 22, 2016 |
|
|
|
|
|
|
|
|
By: |
|
/s/ Stephen Knowles |
|
|
|
|
|
|
Name: Stephen Knowles |
|
|
|
|
|
|
Title: Treasurer |
Ocata Therapeutics, Inc. (NASDAQ:OCAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Ocata Therapeutics, Inc. (NASDAQ:OCAT)
Historical Stock Chart
From Aug 2023 to Aug 2024